polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate · Hospira · NDA 019284
Ocl
Earliest generic entry, as listed
Open now
No marketed reference-listed strength; date taken from all listed strengths.
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 019284 · 001 · discontinued | solution, oral | 6GM/100ML;75MG/100ML;168MG/100ML;146MG/100ML;1.29GM/100ML | open |